Th17 cells in the liver: balancing autoimmunity and pathogen defense

No abstract is available for this paper.

• Publication year

  2022

• Venue

  Seminars in Immunopathology

• Publication date

  2022-02-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00281-022-00917-9PMID 35211777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A Validated Regulatory Network for Th17 Cell Specification.

  2025cited by this paper
• Plasma interleukin-17 and alpha-fetoprotein combination effectively predicts imminent hepatocellular carcinoma occurrence in liver cirrhotic patients

  2021cited by this paper
• PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver disease.

  2021cited by this paper
• Rifaximin reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial.

  2021cited by this paper
• Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial.

  2020cited by this paper
• Inhibition of Sphingosine‐1‐Phosphate‐Induced Th17 Cells Ameliorates Alcohol‐Associated Steatohepatitis in Mice

  2020cited by this paper
• Altered aryl-hydrocarbon-receptor signalling affects regulatory and effector cell immunity in autoimmune hepatitis.

  2020cited by this paper
• Blockade of IL-17 signaling reverses alcohol-induced liver injury and excessive alcohol drinking in mice.

  2020cited by this paper
• Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial.

  2020cited by this paper
• Primary biliary cholangitis: pathogenesis and therapeutic opportunities

  2019influential reference
• Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis

  2019influential reference
• Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming of impaired regeneration pathways in mice.

  2019cited by this paper
• IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.

  2019cited by this paper
• Bidirectional Cross-Talk between Biliary Epithelium and Th17 Cells Promotes Local Th17 Expansion and Bile Duct Proliferation in Biliary Liver Diseases

  2019cited by this paper
• Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis

  2019cited by this paper
• Metabolic regulation of TH17 cells.

  2019cited by this paper
• Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis

  2019cited by this paper
• Dysregulated Lung Commensal Bacteria Drive Interleukin‐17B Production to Promote Pulmonary Fibrosis through Their Outer Membrane Vesicles

  2019cited by this paper
• Targeted Interleukin-22 Gene Delivery in the Liver by Polymetformin and Penetratin-Based Hybrid Nanoparticles to Treat Nonalcoholic Fatty Liver Disease.

  2019cited by this paper
• Metabolic heterogeneity underlies reciprocal fates of TH17 cell stemness and plasticity

  2018cited by this paper
• An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis.

  2018cited by this paper
• IL-17 and IL-17-producing cells and liver diseases, with focus on autoimmune liver diseases.

  2018cited by this paper
• Chronic hepatitis B virus infection.

  2018cited by this paper
• Hepatitis C

  2018cited by this paper
• Organ-specific mechanisms linking innate and adaptive antifungal immunity.

  2018cited by this paper
• ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P.

  2018cited by this paper
• Intestinal host defense outcome is dictated by PGE2 production during efferocytosis of infected cells

  2018cited by this paper
• Intestinal barrier regulates immune responses in the liver via IL-10-producing macrophages.

  2018cited by this paper
• Primary sclerosing cholangitis

  2018cited by this paper
• Bile Acids Activated Receptors Regulate Innate Immunity

  2018cited by this paper
• Type 3 cytokines IL-17A and IL-22 drive TGF-β–dependent liver fibrosis

  2018cited by this paper
• Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism.

  2018cited by this paper
• Bile acid metabolites control Th17 and Treg cell differentiation

  2018cited by this paper
• The Development of Steady-State Activation Hubs between Adult LTi ILC3s and Primed Macrophages in Small Intestine

  2017cited by this paper
• Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation

  2017cited by this paper
• Enhanced Acid Sphingomyelinase Activity Drives Immune Evasion and Tumor Growth in Non-Small Cell Lung Carcinoma.

  2017cited by this paper
• Rising Rate of Liver Transplantation in the Baby Boomer Generation with Non-alcoholic Steatohepatitis in the United States

  2017cited by this paper
• Aryl hydrocarbon receptor (AHR): "pioneer member" of the basic-helix/loop/helix per-Arnt-sim (bHLH/PAS) family of "sensors" of foreign and endogenous signals.

  2017cited by this paper
• Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation

  2017cited by this paper
• The imbalance of Th17/Treg cells is involved in the progression of nonalcoholic fatty liver disease in mice

  2017influential reference
• Activation of the Aryl Hydrocarbon Receptor Interferes with Early Embryonic Development

  2017cited by this paper
• Bilirubin suppresses Th17 immunity in colitis by upregulating CD39.

  2017cited by this paper
• Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease.

  2017cited by this paper
• Mucocutaneous IL-17 immunity in mice and humans: host defense vs. excessive inflammation

  2017cited by this paper
• Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis

  2017influential reference
• Cellular and Molecular Dynamics of Th17 Differentiation and its Developmental Plasticity in the Intestinal Immune Response

  2017cited by this paper
• Interleukin‐17 acts as double‐edged sword in anti‐tumor immunity and tumorigenesis

  2017cited by this paper
• Segmented Filamentous Bacteria Provoke Lung Autoimmunity by Inducing Gut-Lung Axis Th17 Cells Expressing Dual TCRs.

  2017cited by this paper
• Interleukin-22 in human inflammatory diseases and viral infections.

  2017cited by this paper
• Suppression of Inflammatory Arthritis by Human Gut‐Derived Prevotella histicola in Humanized Mice

  2016cited by this paper
• The Human Microbiome during Bacterial Vaginosis

  2016cited by this paper
• Is Hepatocellular Cancer the Same Disease in Alcoholic and Nonalcoholic Fatty Liver Diseases?

  2016cited by this paper
• Interleukin-23-Induced Transcription Factor Blimp-1 Promotes Pathogenicity of T Helper 17 Cells.

  2016cited by this paper
• The features of mucosa‐associated microbiota in primary sclerosing cholangitis

  2016cited by this paper
• The Role of IL-17 Signaling in Regulation of the Liver–Brain Axis and Intestinal Permeability in Alcoholic Liver Disease

  2016cited by this paper
• Interleukin-17A-Induced Epithelial-Mesenchymal Transition of Human Intrahepatic Biliary Epithelial Cells: Implications for Primary Biliary Cirrhosis.

  2016cited by this paper
• CD39 mediated regulation of Th17-cell effector function is impaired in juvenile autoimmune liver disease.

  2016cited by this paper
• Comparative analysis of human and mouse transcriptomes of Th17 cell priming

  2016cited by this paper
• IL-17 in Chronic Inflammation: From Discovery to Targeting.

  2016cited by this paper
• Auto immune hepatitis.

  2016cited by this paper
• Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Is Marked by a Higher Frequency of Th17 Cells in the Liver and an Increased Th17/Resting Regulatory T Cell Ratio in Peripheral Blood and in the Liver

  2016cited by this paper
• Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine

  2016cited by this paper
• Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD

  2016cited by this paper
• Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism.

  2016cited by this paper
• The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls

  2016cited by this paper
• Perturbed Mucosal Immunity and Dysbiosis Accompany Clinical Disease in a Rat Model of Spondyloarthritis

  2016cited by this paper
• Association of IL-17A and IL-17F gene polymorphisms with chronic hepatitis B and hepatitis B virus-related liver cirrhosis in a Chinese population: A case-control study.

  2016cited by this paper
• The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH)

  2016cited by this paper
• Immunology in the liver — from homeostasis to disease

  2016cited by this paper
• Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma.

  2016cited by this paper
• Special Section on Drug Metabolism and the Microbiome—Minireview Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation

  2015cited by this paper
• Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity.

  2015cited by this paper
• IL-17–Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans

  2015cited by this paper
• Interleukin 17A plays a role in lipopolysaccharide/D-galactosamine-induced fulminant hepatic injury in mice.

  2015cited by this paper
• Synergistic effect of pro-inflammatory TNFα and IL-17 in periostin mediated collagen deposition: potential role in liver fibrosis.

  2015cited by this paper
• IL‐22 and IL‐22 binding protein (IL‐22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections

  2015cited by this paper
• Up-regulation of interleukin-22 mediates liver fibrosis via activating hepatic stellate cells in patients with hepatitis C.

  2015cited by this paper
• International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

  2015cited by this paper
• Effector T cell differentiation: are master regulators of effector T cells still the masters?

  2015cited by this paper
• Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.

  2015cited by this paper
• CD5L/AIM Regulates Lipid Biosynthesis and Restrains Th17 Cell Pathogenicity.

  2015cited by this paper
• The Distribution and the Fibrotic Role of Elevated Inflammatory Th17 Cells in Patients With Primary Biliary Cirrhosis

  2015cited by this paper
• Prognostic Significance of the Systemic Inflammatory and Immune Balance in Alcoholic Liver Disease with a Focus on Gender-Related Differences

  2015cited by this paper
• Interleukin-22: immunobiology and pathology.

  2015cited by this paper
• Corrigendum: Sterol metabolism controls TH17 differentiation by generating endogenous RORγ agonists.

  2015cited by this paper
• Discovery and characterization of COVA322, a clinical-stage bispecific TNF/IL-17A inhibitor for the treatment of inflammatory diseases

  2015cited by this paper
• Protective effect of Th22 cells and intrahepatic IL-22 in drug induced hepatocellular injury.

  2015cited by this paper
• TNF-α blockade induces IL-10 expression in human CD4+ T cells

  2014cited by this paper
• The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing

  2014cited by this paper
• Inhibiting RORγt/Th17 axis for autoimmune disorders.

  2014cited by this paper
• 3, 3'-Diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance.

  2014cited by this paper
• Chronic hepatitis B virus infection.

  2014cited by this paper
• The Liver May Act as a Firewall Mediating Mutualism Between the Host and Its Gut Commensal Microbiota

  2014cited by this paper
• Pathological functions of interleukin‐22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment

  2014cited by this paper
• IL-17A Enhances the Expression of Profibrotic Genes through Upregulation of the TGF-β Receptor on Hepatic Stellate Cells in a JNK-Dependent Manner

  2014cited by this paper
• Macrophages and Dendritic Cells Emerge in the Liver during Intestinal Inflammation and Predispose the Liver to Inflammation

  2014cited by this paper
• IL‐12/Th1 and IL‐23/Th17 biliary microenvironment in primary biliary cirrhosis: Implications for therapy

  2014influential reference
• Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORγt induction as downstream targets of Stat3

  2014cited by this paper
• The IL-20 subfamily of cytokines — from host defence to tissue homeostasis

  2014cited by this paper
• Periodontal Pathogens Directly Promote Autoimmune Experimental Arthritis by Inducing a TLR2- and IL-1–Driven Th17 Response

  2014cited by this paper

• The Roles of T Cells in the Development of Metabolic Dysfunction‐Associated Steatohepatitis

  2025cites this paper
• Hepatoprotective potential of M3F, a benzimidazole pyrazole derivative, against paracetamol induced hepatotoxicity

  2025cites this paper
• The impact of T cells on immune-related liver diseases: an overview

  2025cites this paper
• Serpine1 plays a critical role in Th17 cell differentiation and psoriasis pathogenesis

  2025cites this paper
• T lymphocytes linking autoimmunity and cardiovascular disease in aging

  2025cites this paper
• Nanotoxin induces in situ pyroptosis to sensitize αPD1 to ablate metastases in microsattelite stable colorectal cancer.

  2025cites this paper
• Research progress on the mechanism of traditional Chinese medicine in the treatment of autoimmune hepatitis

  2024cites this paper
• Role of T cells in liver metastasis

  2024cites this paper
• Immunological mechanisms in steatotic liver diseases: An overview and clinical perspectives

  2024cites this paper
• Role of the immune system in liver transplantation and its implications for therapeutic interventions

  2023cites this paper
• The role of Th17 cells in endocrine organs: Involvement of the gut, adipose tissue, liver and bone

  2023cites this paper
• Network Approaches to Uncover Pathogenesis and Therapeutic Targets of Inflammatory Bowel Diseases.

  2023cites this paper
• The comparative performance of a custom Canine NanoString® panel on FFPE and snap frozen liver biopsies.

  2023cites this paper
• T cells and liver fibrosis

  2022cites this paper
• The immune response as a therapeutic target in non-alcoholic fatty liver disease

  2022cites this paper
• Immunologic Responses and the Pathophysiology of Primary Biliary Cholangitis.

  2022cites this paper
• γδ T cells: The potential role in liver disease and implications for cancer immunotherapy

  2022cites this paper
• Tolerance and autoimmunity in the liver

  2022cites this paper
• Immunobiotic bacteria attenuate �brosis in Non-alcoholic steatohepatitis mice model: molecular insights and therapeutic potential of immunobiotics for the gut-liver axis

  year unknowncites this paper